Capture of CTCs to be Presented at NEMB Venice Workshop on Cancer Nanotechnology

Published on October 15, 2012 at 7:00 AM

NaturalNano, announced today that Dr. Michael King of Cornell University will present their recent work today at the First NEMB Venice Workshop on Cancer Nanotechnology in Venice, Italy. (http://nemb2012.cism.it)

This Nanobiotechnology presentation will demonstrate that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by the incorporation of NaturalNano's Halloysite Natural Tubes (HNT) onto the surface of devices. These devices are used to capture circulating tumor cells (CTCs) in blood. King's Lab has developing new methods for the isolation of intact, viable cancer cells from patient blood, based on the physiological adhesion of selectin proteins in micro-scale flow devices. Watch Video http://www.jove.com/video/4248

Dr. King, an Associate Professor of biomedical engineering at Cornell University, states, "The ability to create stable coatings of Halloysite nanotubes (HNT) using an extremely thin layer of poly-L-lysine allows the creation of nanostructured surfaces to which living cells respond. The microtubes with HNT incorporated onto their surface were found to enhance the natural CTC rolling mechanism. This allows the cells to be exposed to specific therapeutic agents or isolated and collected for diagnostic and research purposes."

James Wemett, NaturalNano CEO, said, "We are pleased to have our HNT technology used in Dr. King's important work be presented on a global platform. The use of HNT in a medical application is a new area of application for NNAN and we hope that Dr. King's work continues to advance."

Source: http://www.naturalnano.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit